Latest California Healthline Stories
Influx Of Elderly Patients Forces ER To Practice Comfort Care
Despite a culture clash and lack of time and training, ER doctors see how palliative care averts suffering for elderly patients with serious illnesses.
Do Best-Selling Drugs That Calm Stomachs Damage Kidneys? The Answer’s Unclear.
With flawed systems for tracking the side effects of prescription drugs, a link between proton pump inhibitors and kidney disease suggested by research cannot be proven. Patients who swear by the drugs hope it won’t be.
Segregated Living Linked To Higher Blood Pressure Among Blacks
Blood pressure for African-Americans who moved permanently out of segregated areas into medium-segregation locations decreased on average nearly 4 points while those who went to low-segregation locales dropped almost 6 points, a 25-year study finds.
Planned Parenthood Funding Could Thwart GOP Efforts On Health Bill
A provision in the House bill to strip funding from organizations that provide abortions may not meet the strict rules needed to bypass the filibuster in the Senate.
California Bill Addresses Safety Concerns At Dialysis Clinics
Legislation would require minimum staffing levels, longer intervals between patients and more frequent state inspections.
Public Restrooms Become Ground Zero In The Opioid Epidemic
People often turn to public restrooms as a place to get high on opioids. It has led some establishments to close their facilities, while others are training employees to help people who overdose.
For Knee Pain, Experts Say Don’t Think About Scoping It
Writing in the journal BMJ, an international group of experts and patients say arthroscopic surgery on the knee does not provide lasting relief.
Grassley, Chaffetz Send Fiery Response To HHS Memo They Say Chills Whistleblowing
The two Republican lawmakers sent a letter to HHS Secretary Tom Price warning him that whistleblowers in HHS could be intimidated into silence by a department memo instructing employees to get clearance before talking with members of Congress and their staffs.
Nearly 1 In 3 Recent FDA Drug Approvals Followed By Major Safety Actions
More than 70 drugs approved from 2001 through 2010 ran into safety concerns later that resulted in withdrawals from the market, “black box” warnings or other actions.
Louisiana Proposes Tapping A Federal Law To Slash Hepatitis C Drug Prices
Several public health officials endorse using a federal law to slash hepatitis C drug prices in Louisiana and avoid drug bills that could cripple the state budget.